Careers Media center Contacts

Thiotriazolin gets a state award for innovation

Thiotriazolin gets a state award for innovation

22 May 2017 | News

On May 19, an official ceremony was held to award the Cabinet of Ministers of Ukraine Prize Laureate Diplomas to developers of Thiotriazolin. The prize was bestowed on them for creation and manufacturing of the drugs that target cardiovascular and ophthalmic diseases and improve the immunological response of the organism.

Established by the Cabinet of Ministers of Ukraine in 2012, the prize is awarded annually for outstanding achievements in the development and introduction of new technologies in production, as well as for launching innovative domestic products.

Thiotriazolin is one of Arterium Corporation's original medicinal products. A cardioprotective drug, it is used in the treatment of coronary artery disease (CAD). Its manufacturing was launched back in 1994, when Galychpharm in cooperation with Pharmatron started making Thiotriazolin in the form of injection solution in ampoules. In 1995, production of Thiotriazolin in tablets followed.

Media gallery
dfdrfd
PRESS KIT

Here you can find general information about the company intended for journalists and other stakeholders

MEDIA CONTACTS

For all media-related enquiries,
please contact us
e-mail: pr@arterium.ua
mob.: +38050 446 71 20, +38095 278 92 80